Sacrificing quality for quantity? RE: Clinical Benefits and Cost-effectiveness of Allogeneic Red Blood Cell Transfusion in Severe Symptomatic Anemia A. M. Beliaev, R. J. Marshall, M. Gordon, W. Smith and J. A. Windsor

A. Shander, O. Aregbeyen, M. Caylan

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish
Pages (from-to)360-361
Number of pages2
JournalVox Sanguinis
Volume103
Issue number4
DOIs
StatePublished - Nov 2012

Cite this